Published in Vaccine Weekly, September 11th, 2002
PowderJect Pharmaceuticals, PLC, said it made the move regarding its BCG [bacillus Calmette-Guerin] vaccine, which is used in schools, after being notified of an interim suspension of the company's license for the vaccine in Ireland. That move followed testing that found a small number of batches did not meet the end-of-shelf-life specification, the company said in a statement.
"The regulators are satisfied that there are no related safety implications, although the batches were potentially less potent than...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly